- Home
- / Rheos Medicines
Rheos Medicines
Total Funding
$60 M
Rheos Medicines Summary
Company Summary
- Overview
- Rheos Medicines (formerly known as Immunometabolism Newco) is a biopharmaceutical company that develops medicines for metabolic pathways in immune cells. It offers therapeutics for autoimmune diseases.
- Type
- Private
- Status
- Active
- Founded
- 2013
- HQ
- Cambridge, MA, US | view all locations
- Website
- https://rheosrx.com/
- Cybersecurity rating
Table of Contents
Key People
Dania Rabah, Chief Scientific Officer
Nirupama Subramanian, Chief Operating Officer
Edward Driggers, Founder and Chief Technology Officer
LocationsView all
1 location detected
Cambridge, MA HQ
United States
38 Sidney St